Studying Normal Breast Tissue and Cancer Risk
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00341692|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : April 5, 2018
Breast cancer is the most common cancer among women in the United States. Breast cancer research has been hampered by the difficulty in collecting normal breast tissue. In this study, researchers will obtain samples of normal breast tissue from organ donors and will collect risk-factor data from next-of-kin.
The purpose of this study is to learn how normal breast develops and responds to stresses that are known to increase a woman s chance of developing breast cancer.
Following the breast-tissue donation from 20 volunteers, surgical technicians will make small incisions in the skin and tissue of the breast and remove several samples measuring about one-inch. Technicians also will take samples of the uterine lining to estimate the date of the last menstrual period. The tissue will then be sent to the National Cancer Institute for laboratory research studies. Steps will be taken to ensure that the identity of the participants remains confidential.
|Condition or disease|
|Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases|
|Study Type :||Observational|
|Actual Enrollment :||13 participants|
|Official Title:||Pilot Study to Collect Normal Breast Tissue From Organ and Tissue Donors|
|Study Start Date :||April 7, 2003|
- Histological features [ Time Frame: cross-sectional ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00341692
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Gretchen Benson, Ph.D.||National Cancer Institute (NCI)|